 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 200
Date: November 16, 2024
The human immune system must perform a delicate balancing act between safeguarding its own vital tissues and at the same time aggressively destroying pathogens and cancers.
Recent breakthrough research is revealing the details of how this actually happens. Some T-cells are potent killers, willing and able to hunt down virally infected cells and cancer cells. To balance these, there are other T-cells that provide regulatory oversight, keeping the killers under check. Too many killer cells and too few regulatory cells means the risk of autoimmune disease, where the body is destroyed by overexuberant killer T-cells. But too many regulatory cells means nothing gets done, viruses and cancers can flourish with no one to stop them.
We review the critical role of these important players in our latest article bearing the title Tregs Revealed. Understanding how these cells function and their delicate balance is central to making good therapy decisions for CLL patients.
Be well,
Chaya
______
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
